HCA Healthcare, Inc. $HCA Stock Bought by Hourglass Capital LLC

Key Points

• Hourglass Capital increased its HCA Healthcare stake by 14.8% in the third quarter, bringing its holdings to 19,110 shares valued at approximately $8.16 million. Institutional investors collectively own 62.73% of HCA stock.
• HCA reported quarterly earnings of $7.59 per share, slightly exceeding estimates, while revenue rose 8.7% year over year to $20.23 billion. Analysts expect full-year earnings of $29.51 per share.
• Wall Street maintains a “Moderate Buy” consensus on HCA, with 16 Buy, six Hold, and one Sell rating and an average price target of $467.50.

Hourglass Capital LLC increased its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 14.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,110 shares of the company's stock after purchasing an additional 2,470 shares during the quarter. HCA Healthcare makes up 1.7% of Hourglass Capital LLC's investment portfolio, making the stock its 20th largest holding. Hourglass Capital LLC's holdings in HCA Healthcare were worth $8,155,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. Sunbelt Securities Inc. lifted its stake in HCA Healthcare by 171.7% in the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company's stock valued at $2,954,000 after buying an additional 3,945 shares during the period. Sei Investments Co. increased its stake in HCA Healthcare by 27.5% in the first quarter. Sei Investments Co. now owns 467,796 shares of the company's stock valued at $221,380,000 after purchasing an additional 100,764 shares in the last quarter. SEB Asset Management AB acquired a new stake in HCA Healthcare in the first quarter worth $75,534,000. Darsana Capital Partners LP increased its position in shares of HCA Healthcare by 46.7% in the 2nd quarter. Darsana Capital Partners LP now owns 1,100,000 shares of the company's stock valued at $428,879,000 after buying an additional 350,000 shares in the last quarter. Finally, Fund 1 Investments LLC acquired a new stake in HCA Healthcare during the 2nd quarter worth $975,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 1.0%

Shares of HCA opened at $464.45 on Tuesday. The company has a market cap of $100.55 billion, a price-to-earnings ratio of 15.79, a PEG ratio of 1.58 and a beta of 1.10. The company's fifty day simple moving average is $431.57 and its 200 day simple moving average is $445.15. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analysts' expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the business posted $6.84 earnings per share. As a group, research analysts forecast that HCA Healthcare, Inc. will post 29.51 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on HCA shares. UBS Group dropped their price target on HCA Healthcare from $635.00 to $579.00 and set a "buy" rating on the stock in a research report on Monday, July 27th. Leerink Partners restated an "outperform" rating and set a $492.00 target price on shares of HCA Healthcare in a report on Friday, September 18th. Royal Bank Of Canada lifted their price target on shares of HCA Healthcare from $435.00 to $496.00 and gave the company an "outperform" rating in a research note on Wednesday, October 7th. Barclays lowered their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating for the company in a research report on Monday, July 27th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating on shares of HCA Healthcare in a research report on Friday, October 2nd. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, HCA Healthcare has a consensus rating of "Moderate Buy" and an average target price of $467.50.

HCA Healthcare Profile

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women's and children's services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.